292 related articles for article (PubMed ID: 16937488)
21. Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome.
Lindor NM
Surg Oncol Clin N Am; 2009 Oct; 18(4):637-45. PubMed ID: 19793571
[TBL] [Abstract][Full Text] [Related]
22. Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis.
Jasperson KW; Vu TM; Schwab AL; Neklason DW; Rodriguez-Bigas MA; Burt RW; Weitzel JN
Fam Cancer; 2010 Jun; 9(2):99-107. PubMed ID: 19731080
[TBL] [Abstract][Full Text] [Related]
23. Update on Hereditary Colorectal Cancer.
DA Silva FC; Wernhoff P; Dominguez-Barrera C; Dominguez-Valentin M
Anticancer Res; 2016 Sep; 36(9):4399-405. PubMed ID: 27630275
[TBL] [Abstract][Full Text] [Related]
24. The identification of Lynch syndrome in Congolese colorectal cancer patients.
Poaty H; Aba Gandzion C; Soubeyran I; Gassaye D; Peko JF; Nkoua Bon JB; Gombé Mbalawa C
Bull Cancer; 2017 Oct; 104(10):831-839. PubMed ID: 28988047
[TBL] [Abstract][Full Text] [Related]
25. Genetic susceptibility to non-polyposis colorectal cancer.
Lynch HT; de la Chapelle A
J Med Genet; 1999 Nov; 36(11):801-18. PubMed ID: 10544223
[TBL] [Abstract][Full Text] [Related]
26. Lynch syndrome and MYH-associated polyposis: review and testing strategy.
Goodenberger M; Lindor NM
J Clin Gastroenterol; 2011 Jul; 45(6):488-500. PubMed ID: 21325953
[TBL] [Abstract][Full Text] [Related]
27. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
[TBL] [Abstract][Full Text] [Related]
28. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing.
Riegert-Johnson DL; Johnson RA; Rabe KG; Wang L; Thomas B; Baudhuin LM; Thibodeau SN; Boardman LA
Genet Test; 2007; 11(4):361-5. PubMed ID: 18294051
[TBL] [Abstract][Full Text] [Related]
29. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
Stoffel EM
Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
[TBL] [Abstract][Full Text] [Related]
30. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
[TBL] [Abstract][Full Text] [Related]
31. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
[TBL] [Abstract][Full Text] [Related]
32. [Lynch syndrome I: a case report].
Zivković V; Katić V; Gligorijević J; Andelković Z; Petrović A; Krstić M
Med Pregl; 2008; 61(1-2):79-82. PubMed ID: 18798480
[TBL] [Abstract][Full Text] [Related]
33. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
Ponti G; Manfredini M; Tomasi A; Pellacani G
Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
[TBL] [Abstract][Full Text] [Related]
34. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
[TBL] [Abstract][Full Text] [Related]
35. Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing.
Palmirotta R; Matera S; Curia MC; Aceto G; el Zhobi B; Verginelli F; Guadagni F; Casale V; Stigliano V; Messerini L; Mariani-Costantini R; Battista P; Cama A
Fam Cancer; 2004; 3(2):117-21. PubMed ID: 15340262
[TBL] [Abstract][Full Text] [Related]
36. Hereditary non-polyposis colorectal cancer (HNPCC): new germline mutation (190-191 del AA) in the human MLH1 gene and review of clinical guidelines for surveillance of affected families.
Schiemann U; Papatheodorou L; Glasl S; Gross M
Eur J Med Res; 2001 Mar; 6(3):93-100. PubMed ID: 11309221
[TBL] [Abstract][Full Text] [Related]
37. Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome.
Kidambi TD; Blanco A; Van Ziffle J; Terdiman JP
Fam Cancer; 2016 Apr; 15(2):275-80. PubMed ID: 26781822
[TBL] [Abstract][Full Text] [Related]
38. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
[TBL] [Abstract][Full Text] [Related]
39. Pathology of the hereditary colorectal carcinoma.
Gatalica Z; Torlakovic E
Fam Cancer; 2008; 7(1):15-26. PubMed ID: 17564815
[TBL] [Abstract][Full Text] [Related]
40. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
Zhang YZ; Sheng JQ; Li SR; Wu ZT
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
